380 related articles for article (PubMed ID: 31695427)
21. Tumor cell-induced platelet aggregation accelerates hematogenous metastasis of malignant melanoma by triggering macrophage recruitment.
Chen Y; Zhou J; Liu Z; Wu T; Li S; Zhang Y; Yin X; Yang G; Zhang G
J Exp Clin Cancer Res; 2023 Oct; 42(1):277. PubMed ID: 37872588
[TBL] [Abstract][Full Text] [Related]
22. Tumor-associated macrophages contribute to tumor progression in ovarian cancer.
Colvin EK
Front Oncol; 2014; 4():137. PubMed ID: 24936477
[TBL] [Abstract][Full Text] [Related]
23. Ovarian low and high grade serous carcinomas: hidden divergent features in the tumor microenvironment.
Ciucci A; Zannoni GF; Buttarelli M; Martinelli E; Mascilini F; Petrillo M; Ferrandina G; Scambia G; Gallo D
Oncotarget; 2016 Oct; 7(42):68033-68043. PubMed ID: 27462782
[TBL] [Abstract][Full Text] [Related]
24. ASK1-dependent endothelial cell activation is critical in ovarian cancer growth and metastasis.
Yin M; Zhou HJ; Zhang J; Lin C; Li H; Li X; Li Y; Zhang H; Breckenridge DG; Ji W; Min W
JCI Insight; 2017 Sep; 2(18):. PubMed ID: 28931753
[TBL] [Abstract][Full Text] [Related]
25. Human tumor-associated monocytes/macrophages and their regulation of T cell responses in early-stage lung cancer.
Singhal S; Stadanlick J; Annunziata MJ; Rao AS; Bhojnagarwala PS; O'Brien S; Moon EK; Cantu E; Danet-Desnoyers G; Ra HJ; Litzky L; Akimova T; Beier UH; Hancock WW; Albelda SM; Eruslanov EB
Sci Transl Med; 2019 Feb; 11(479):. PubMed ID: 30760579
[TBL] [Abstract][Full Text] [Related]
26. M2 tumor-associated macrophages promote tumor progression in non-small-cell lung cancer.
Sumitomo R; Hirai T; Fujita M; Murakami H; Otake Y; Huang CL
Exp Ther Med; 2019 Dec; 18(6):4490-4498. PubMed ID: 31777551
[TBL] [Abstract][Full Text] [Related]
27. Exosomes released from PD-L1
Ma J; Cen Q; Wang Q; Liu L; Zhou J
Biochem Biophys Rep; 2023 Dec; 36():101542. PubMed ID: 37822876
[TBL] [Abstract][Full Text] [Related]
28. Role of Tumor-Associated Macrophages in Cervical Cancer: Integrating Classical Perspectives with Recent Technological Advances.
Choi Y; Lee D; Kim NY; Seo I; Park NJ; Chong GO
Life (Basel); 2024 Mar; 14(4):. PubMed ID: 38672714
[TBL] [Abstract][Full Text] [Related]
29. Correlations of tumor-associated macrophage subtypes with liver metastases of colorectal cancer.
Cui YL; Li HK; Zhou HY; Zhang T; Li Q
Asian Pac J Cancer Prev; 2013; 14(2):1003-7. PubMed ID: 23621176
[TBL] [Abstract][Full Text] [Related]
30. Tumor-associated macrophage expression of PD-L1 in implants of high grade serous ovarian carcinoma: A comparison of matched primary and metastatic tumors.
Gottlieb CE; Mills AM; Cross JV; Ring KL
Gynecol Oncol; 2017 Mar; 144(3):607-612. PubMed ID: 28065619
[TBL] [Abstract][Full Text] [Related]
31. PD-L1 expression on tumor-infiltrating immune cells is highly associated with M2 TAM and aggressive malignant potential in patients with resected non-small cell lung cancer.
Sumitomo R; Hirai T; Fujita M; Murakami H; Otake Y; Huang CL
Lung Cancer; 2019 Oct; 136():136-144. PubMed ID: 31499335
[TBL] [Abstract][Full Text] [Related]
32. Upregulation of IGF1 by tumor-associated macrophages promotes the proliferation and migration of epithelial ovarian cancer cells.
Liu L; Wang X; Li X; Wu X; Tang M; Wang X
Oncol Rep; 2018 Feb; 39(2):818-826. PubMed ID: 29251331
[TBL] [Abstract][Full Text] [Related]
33. Tumor-associated macrophages promote invasion via Toll-like receptors signaling in patients with ovarian cancer.
Ke X; Zhang S; Wu M; Lou J; Zhang J; Xu T; Huang L; Huang P; Wang F; Pan S
Int Immunopharmacol; 2016 Nov; 40():184-195. PubMed ID: 27608303
[TBL] [Abstract][Full Text] [Related]
34. PD-L1 expression is associated with tumor-infiltrating T cells and favorable prognosis in high-grade serous ovarian cancer.
Webb JR; Milne K; Kroeger DR; Nelson BH
Gynecol Oncol; 2016 May; 141(2):293-302. PubMed ID: 26972336
[TBL] [Abstract][Full Text] [Related]
35. Expression of scavenger receptor MARCO defines a targetable tumor-associated macrophage subset in non-small cell lung cancer.
La Fleur L; Boura VF; Alexeyenko A; Berglund A; Pontén V; Mattsson JSM; Djureinovic D; Persson J; Brunnström H; Isaksson J; Brandén E; Koyi H; Micke P; Karlsson MCI; Botling J
Int J Cancer; 2018 Oct; 143(7):1741-1752. PubMed ID: 29667169
[TBL] [Abstract][Full Text] [Related]
36. Tumor-associated macrophages: role in cancer development and therapeutic implications.
Salmaninejad A; Valilou SF; Soltani A; Ahmadi S; Abarghan YJ; Rosengren RJ; Sahebkar A
Cell Oncol (Dordr); 2019 Oct; 42(5):591-608. PubMed ID: 31144271
[TBL] [Abstract][Full Text] [Related]
37. The increase of circulating PD-L1-expressing CD68(+) macrophage in ovarian cancer.
Qu QX; Huang Q; Shen Y; Zhu YB; Zhang XG
Tumour Biol; 2016 Apr; 37(4):5031-7. PubMed ID: 26541760
[TBL] [Abstract][Full Text] [Related]
38. The perivascular microenvironment in Epstein-Barr virus positive primary central nervous system lymphoma: The role of programmed cell death 1 and programmed cell death ligand 1.
Sugita Y; Furuta T; Ohshima K; Komaki S; Miyoshi J; Morioka M; Abe H; Nozawa T; Fujii Y; Takahashi H; Kakita A
Neuropathology; 2018 Apr; 38(2):125-134. PubMed ID: 29067721
[TBL] [Abstract][Full Text] [Related]
39. Programmed Cell Death Ligand 1 (PD-L1) Signaling Regulates Macrophage Proliferation and Activation.
Hartley GP; Chow L; Ammons DT; Wheat WH; Dow SW
Cancer Immunol Res; 2018 Oct; 6(10):1260-1273. PubMed ID: 30012633
[TBL] [Abstract][Full Text] [Related]
40. The Role of Macrophage/B-Cell Interactions in the Pathophysiology of B-Cell Lymphomas.
Pham LV; Pogue E; Ford RJ
Front Oncol; 2018; 8():147. PubMed ID: 29868471
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
